Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Zevra Therapeutics, Inc. - Common Stock (NQ:ZVRA)

11.68 -0.06 (-0.51%)
Streaming Delayed Price Updated: 11:40 AM EDT, Aug 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 161,900
Open 11.74
Bid (Size) 11.67 (200)
Ask (Size) 11.70 (400)
Prev. Close 11.74
Today's Range 11.62 - 11.80
52wk Range 7.160 - 15.04
Shares Outstanding 33,932,639
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zevra Therapeutics, Inc. - ZVRA
From Pomerantz LLP
Via GlobeNewswire
News headline image
Zevra Therapeutics Q2 Earnings Call Highlights ↗
Zevra Therapeutics (NASDAQ:ZVRA) reported second-quarter 2026 net revenue of $39.7 million, up 53% from $25.9 million a year earlier, driven primarily by U.S. sales of its Niemann-Pick disease type C... 
Via MarketBeat
Topics Earnings

Performance

YTD
+40.0%
+40.0%
1 Month
+20.3%
+20.3%
3 Month
+6.7%
+6.7%
6 Month
+30.8%
+30.8%
1 Year
+24.1%
+24.1%

More News

Read More
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zevra Therapeutics, Inc. - ZVRA
From Pomerantz LLP
Via GlobeNewswire
News headline image
ZVRA Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Zevra Therapeutics (ZVRA)
From Levi & Korsinsky, LLP
Via Business Wire
Zevra Therapeutics (NASDAQ:ZVRA) Shares Surge After Blowout Q1 Earnings Beat ↗
Via Chartmill
Zevra Therapeutics Inc (NASDAQ:ZVRA) Stock Surges 21% After Blowing Past Q4 Earnings Estimates ↗
Via Chartmill
News headline image
ZVRA Investors Have Opportunity to Join Zevra Therapeutics, Inc. Fraud Investigation with SBS Law
From Schall, Brown & Schwartz LLP
Via Business Wire
These stocks are gapping in today's session ↗
Via Chartmill
These stocks are moving in today's pre-market session ↗
Via Chartmill
News headline image
Zevra (ZVRA) Q1 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings Intellectual Property
News headline image
Earnings Scheduled For November 5, 2025 ↗
Via Benzinga
News headline image
Why Zevra Therapeutics Stock Zoomed 21% Higher Today ↗
Via The Motley Fool
Gapping stocks in Tuesday's session ↗
Via Chartmill
Stay updated with the stocks that are on the move in today's pre-market session. ↗
Via Chartmill
News headline image
Nasdaq, S&P 500 Futures Turn Green On Iran War De-Escalation Signals: Why NVDA, ORCL, JOBY, VRTX, ZVRA Are On Traders' Radar Today ↗
Via Stocktwits
Topics Artificial Intelligence ETFs Government
News headline image
Dow, S&P 500, Nasdaq Futures Dip After Wall Street Rebound: Why SLS, ZVRA, RLMD, USO, CASY Are Trending After-Hours ↗
Via Stocktwits
Topics ETFs Government Stocks
News headline image
ZVRA Stock Soars On Upbeat Q4 Results, Optimism For EMA Approval Of Niemann-Pick Disease Treatment ↗
Via Stocktwits
Top movers in Monday's after hours session ↗
Via Chartmill
News headline image
Zevra Therapeutics Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
From Johnson Fistel, PLLP
Via Business Wire
News headline image
This Biotech Is Up 194% in a Year but One Investor Took Millions Off the Table ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
ANI Stock Is Up 49% This Past Year, Revenue Is Surging, and One Fund Still Walked Away ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Zevra (ZVRA) Q3 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Top Stocks With Earnings This Week: Joby, IonQ, AMD and More ↗
Via Benzinga
News headline image
Zevra Therapeutics' Stock Soars on Strong Performance and Strategic Wins: What It Means for Investors
Via MarketMinute
News headline image
Why PepGen Shares Are Trading Higher By 112%; Here Are 20 Stocks Moving Premarket ↗
Via Benzinga

Frequently Asked Questions

Is Zevra Therapeutics, Inc. - Common Stock publicly traded?
Yes, Zevra Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Zevra Therapeutics, Inc. - Common Stock trade on?
Zevra Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Zevra Therapeutics, Inc. - Common Stock?
The ticker symbol for Zevra Therapeutics, Inc. - Common Stock is ZVRA on the Nasdaq Stock Market
What is the current price of Zevra Therapeutics, Inc. - Common Stock?
The current price of Zevra Therapeutics, Inc. - Common Stock is 11.68
When was Zevra Therapeutics, Inc. - Common Stock last traded?
The last trade of Zevra Therapeutics, Inc. - Common Stock was at 08/27/26 11:40 AM ET
What is the market capitalization of Zevra Therapeutics, Inc. - Common Stock?
The market capitalization of Zevra Therapeutics, Inc. - Common Stock is 396.33M
How many shares of Zevra Therapeutics, Inc. - Common Stock are outstanding?
Zevra Therapeutics, Inc. - Common Stock has 396M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.